A Personalized Care Pathway for Heart Attack Prevention

Picture of Cleerly Cleerly : December 4, 2023

heart attack prevention heart disease technology
A Personalized Care Pathway for Heart Attack Prevention

In Today’s Medical Developments, Cleerly founder and CEO Dr. James K. Min explains why the current approach to cardiovascular care is flawed — and prevents personalized care. Cleerly’s AI-enabled technology solves many of these problems with its precise, whole-heart phenotyping. Read the full article

 

 
AI Leading the Way to More Precise Diagnostics and Disease Risk Prediction

AI Leading the Way to More Precise Diagnostics and Disease Risk Prediction

Picture of Cleerly Cleerly: February 15, 2024

Inside Precision Medicine features our Chief Scientific Officer, Dr. Udo Hoffmann, on how AI has changed CT imaging and the TRANSFORM trial that may...

heart attack prevention heart disease technology
Read More
Digital Health 50: The Most Promising Digital Health Companies of 2023

Digital Health 50: The Most Promising Digital Health Companies of 2023

Picture of Cleerly Cleerly: December 27, 2023

Selected from more than 10,000 private healthcare companies, Cleerly is named one of CB Insight’s Digital Health 50 based on R&D, Mosaic scores,...

heart attack prevention heart disease technology
Read More
In Pursuit Of: Brilliant Minds in Healthcare

In Pursuit Of: Brilliant Minds in Healthcare

Picture of Cleerly Cleerly: December 27, 2023

Nasdaq interviews CEO Dr. James K. Min, one of their 18 “Brilliant Minds in Healthcare,” about Cleerly’s founding, his vision for the company, and...

heart attack prevention heart disease technology
Read More